These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31798978)

  • 21. D2-40/podoplanin expression in cancer stroma by immunohistochemical staining is associated with poor prognosis in bladder cancer patients after radical cystectomy.
    Okajima E; Tomizawa M; Shimada K; Negishi T; Nishiyama N; Kitamura H
    Urol Oncol; 2020 Oct; 38(10):797.e7-797.e13. PubMed ID: 32576528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
    Sahwi A; Robert M; Delbos O; Legouffe E; Guiter J; Navratil H
    Prog Urol; 1998 Dec; 8(6):1007-11. PubMed ID: 9894259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rare bladder cancer--small cell carcinoma: review and update.
    Ismaili N
    Orphanet J Rare Dis; 2011 Nov; 6():75. PubMed ID: 22078012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder Cancer.
    Chakiryan NH; Jiang DD; Gillis KA; Green E; Hajiran A; Hugar L; Zemp L; Zhang J; Jain R; Chahoud J; Poch M; Manley BJ; Li R; Sexton W; Gilbert SM
    J Urol; 2021 Oct; 206(4):924-932. PubMed ID: 34032503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer.
    Huo J; Ray-Zack MD; Shan Y; Chamie K; Boorjian SA; Kerr P; Jana B; Freedland SJ; Kamat AM; Mehta HB; Williams SB
    Eur Urol Oncol; 2019 Sep; 2(5):497-504. PubMed ID: 31411998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder Cancer.
    Jiang DM; Jiang H; Chung PWM; Zlotta AR; Fleshner NE; Bristow RG; Berlin A; Kulkarni GS; Alimohamed NS; Lo G; Sridhar SS
    Clin Genitourin Cancer; 2019 Feb; 17(1):38-45. PubMed ID: 30686350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder.
    Kaushik D; Frank I; Boorjian SA; Cheville JC; Eisenberg MS; Thapa P; Tarrell RF; Thompson RH
    Int J Urol; 2015 Jun; 22(6):549-54. PubMed ID: 25761779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer.
    Kitagawa Y; Izumi K; Miwa S; Kadono Y; Konaka H; Mizokami A; Namiki M
    Anticancer Res; 2013 Oct; 33(10):4497-503. PubMed ID: 24123021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Effective and Well Tolerated Strategy of Bladder Preservation Therapy in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer.
    Feng YH; Shen KH; Huang KH; Tzeng WS; Li CF; Lin KL
    Clin Genitourin Cancer; 2016 Feb; 14(1):e67-74. PubMed ID: 26428609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of platinum-based adjuvant chemotherapy for muscle-invasive bladder cancer: A weighted propensity score analysis.
    Shimizu F; Muto S; Taguri M; Ieda T; Tsujimura A; Sakamoto Y; Fujita K; Okegawa T; Yamaguchi R; Horie S
    Int J Urol; 2017 May; 24(5):367-372. PubMed ID: 28281310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer-specific mortality following radical cystectomy for bladder cancer with lymph node involvement: impact of pathologic disease features and adjuvant chemotherapy.
    Clifton MM; Psutka SP; Boorjian SA; Cheville JC; Thapa P; Thompson RH; Tollefson MK; Karnes RJ; Frank I
    World J Urol; 2015 Mar; 33(3):373-9. PubMed ID: 24833245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation.
    Zargar-Shoshtari K; Sverrisson EF; Sharma P; Gupta S; Poch MA; Pow-Sang JM; Spiess PE; Sexton WJ
    Clin Genitourin Cancer; 2016 Feb; 14(1):82-8. PubMed ID: 26411593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neo-adjuvant and adjuvant chemotherapy of bladder cancer: Is there a role?
    Sternberg CN
    Ann Oncol; 2002; 13 Suppl 4():273-9. PubMed ID: 12401701
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and safety of systemic chemotherapy and intra-arterial chemotherapy with/without radiotherapy for bladder preservation or as neo-adjuvant therapy in patients with muscle-invasive bladder cancer: a single-centre study of 163 patients.
    Miyata Y; Nomata K; Ohba K; Matsuo T; Hayashi N; Sakamoto I; Uetani M; Sakai H
    Eur J Surg Oncol; 2015 Mar; 41(3):361-7. PubMed ID: 25312685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer.
    Hermans TJN; Voskuilen CS; Deelen M; Mertens LS; Horenblas S; Meijer RP; Boormans JL; Aben KK; van der Heijden MS; Pos FJ; de Wit R; Beerepoot LV; Verhoeven RHA; van Rhijn BWG
    Int J Cancer; 2019 Mar; 144(6):1453-1459. PubMed ID: 30155893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy.
    Mazzone E; Nazzani S; Knipper S; Tian Z; Preisser F; Gallina A; Soulières D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Wisnivesky J; Karakiewicz PI
    Eur J Surg Oncol; 2019 Jul; 45(7):1253-1259. PubMed ID: 30755341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical review - small cell carcinoma of the bladder.
    Church DN; Bahl A
    Cancer Treat Rev; 2006 Dec; 32(8):588-93. PubMed ID: 17008012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion.
    Rosiello G; Knipper S; Palumbo C; Pecoraro A; Luzzago S; Deuker M; Tian Z; Gandaglia G; Gallina A; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Clin Genitourin Cancer; 2020 Feb; 18(1):35-44.e1. PubMed ID: 31711842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The nested variant of bladder transitional cell carcinoma: Review of 12 cases and review of the literature.
    Carrion-Ballardo CJ; Gala-Solana L; Portillo-Martin JA; Azueta-Etxebarria A; Truan-Cacho D; Campos-Juanatey F
    Actas Urol Esp; 2015; 39(6):387-91. PubMed ID: 25670479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution.
    Peyromaure M; Slama J; Beuzeboc P; Ponvert D; Debré B; Zerbib M
    Urology; 2004 Jan; 63(1):73-7. PubMed ID: 14751352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.